Fundies. English
Segment disclosures
Company overviewFOXO TECHNOLOGIES INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
12 dimension combinations 65 retained observations 16 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Labs And Life · All Other Segments
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=FOXO:LabsAndLifeMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-06-30 | 15000 | USD | 20240819 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 25000 | USD | 20240819 | Open filing evidence |
Health Care · All Other Segments
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCareMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-06-30 | 20000 | USD | 20240819 | Open filing evidence |
FOXO Labs · All Other Segments
Title Of Individual · Statement Business Segments
Source dimensions
srt:TitleOfIndividualAxis=foxo:FOXOLabsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 4000 | USD | 20240628 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 126000 | USD | 20240606 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 7000 | USD | 20240628 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 483000 | USD | 20240606 | Open filing evidence |
FOXO Life · All Other Segments
Title Of Individual · Statement Business Segments
Source dimensions
srt:TitleOfIndividualAxis=foxo:FOXOLifeMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 3000 | USD | 20240628 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 19000 | USD | 20240606 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 6000 | USD | 20240628 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 28000 | USD | 20240606 | Open filing evidence |
FOXO Technologies Inc · All Other Segments
Title Of Individual · Statement Business Segments
Source dimensions
srt:TitleOfIndividualAxis=foxo:FOXOTechnologiesIncMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 7000 | USD | 20240628 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 145000 | USD | 20240606 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 13000 | USD | 20240628 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 511000 | USD | 20240606 | Open filing evidence |
Health Cares
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=FOXO:HealthCaresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 4470352 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 9268903 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 4798551 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 16086099 | USD | 20260415 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3508480 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11880468 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 5210557 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8371988 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 3161431 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 4018961 | USD | 20260415 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1187805 Restated | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1207992 Restated | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 20187 Restated | USD | 20250819 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 20187 | USD | 20250819 | Open filing evidence |
Labs And Life
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=FOXO:LabsAndLifeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 8489 | USD | 20250819 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 32640 | USD | 20250415 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 8000 | USD | 20241119 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 23000 | USD | 20241119 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 8000 | USD | 20240819 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7180 | USD | 20250819 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 145291 | USD | 20250415 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 10000 | USD | 20241119 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 35000 | USD | 20241119 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 12000 | USD | 20240819 | Open filing evidence |
Labs
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=FOXO:LabsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 6202 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 14437 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 4386 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 13923 | USD | 20260415 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 8242 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 24547 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 7816 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 16305 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 8489 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 32640 | USD | 20260415 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 8752 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 23219 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 7287 | USD | 20250819 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 14467 | USD | 20250819 | Open filing evidence |
Life Science Services
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=FOXO:LifeScienceServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 238462 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 599712 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 361250 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 252502 | USD | 20260415 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 31630 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 31630 | USD | 20251110 | Open filing evidence |
Revenue
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=foxo:RevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 511000 | USD | 20230721 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 120000 | USD | 20230721 | Open filing evidence |
All Other Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 145000 | USD | 20240606 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 511000 | USD | 20240606 | Open filing evidence |
Corporate And Other
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 3849 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 15093 | USD | 20260415 | Open filing evidence |